Literature DB >> 18058976

Prenatal diagnosis of congenital lipoid adrenal hyperplasia (CLAH) by estriol amniotic fluid analysis and molecular genetic testing.

Amy Jean1, Mahesh Mansukhani, Sharon E Oberfield, Ilene Fennoy, Jon Nakamoto, Maha Atwan, Israela Lerer, Ziva Ben Neriah, David H Zangen, Wendy K Chung.   

Abstract

OBJECTIVE: Congenital lipoid adrenal hyperplasia is an autosomal recessive condition due to mutations in Steroidogenic Acute Regulatory Protein (StAR) associated with the inability to synthesize all adrenal and gonadal steroids, resulting in adrenal insufficiency and failure to develop male genitalia in affected 46,XY individuals. We used two independent methods of prenatal diagnosis for CLAH.
METHOD: CLAH was diagnosed prenatally by measuring amniotic fluid estriol, adrenal, and gonadal hormone levels, and by mutation analysis for the c.201-202 delCT mutation in StAR.
RESULTS: Prenatal testing diagnosed one affected and three unaffected fetuses in two families at risk for CLAH.
CONCLUSION: Prenatal testing for CLAH is effective, and targeted molecular genetic analysis should be considered in Palestinian families with a fetus with discordant 46,XY karyotype and female genitalia on ultrasound, and low maternal serum estriol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18058976     DOI: 10.1002/pd.1906

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  1 in total

1.  Prenatal diagnosis of congenital lipoid adrenal hyperplasia (CLAH) by molecular genetic testing in Korean siblings.

Authors:  Hyun Sun Ko; Seungok Lee; Hyojin Chae; Sae Kyung Choi; Myungshin Kim; In Yang Park; Byung Kyu Suh; Jong Chul Shin
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.